Paid Clinical Trials Gulfport

Discover 7 paid clinical trials in Gulfport, Mississippi. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 7

LY900040A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Recruiting

PHASE3

Sponsor:

Eli Lilly and Company

Location:

Gulfport MS, Lafayette LA, Atlanta GA, Houston TXshow 11 more

Code:

NCT06672549

Conditions

Obesity

Overweight

Eligibility Criteria

Sex: All

Age: 6 - 17

Healthy Volunteers: Not accepted

Interventions

Orforglipron

Placebo

Investigational CMV Vaccine Study for Volunteers Ages 9–15Investigational CMV Vaccine Study for Volunteers Ages 9–15

PHASE1

PHASE2

Sponsor:

Moderna

Location:

Gulfport MS, Covington LA, New Orleans LA, Birmingham ALshow 43 more

Code:

NCT05575492

Conditions

Cytomegalovirus

Eligibility Criteria

Sex: All

Age: 9 - 15

Healthy Volunteers: Accepted

Interventions

mRNA-1647

Placebo

Epcoritamab & LenalidomideA Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Recruiting

PHASE3

Sponsor:

Genmab

Location:

Gulfport MS, Knoxville TN, Wichita KS, Dyer INshow 4 more

Code:

NCT06508658

Conditions

Diffuse Large B-Cell Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Epcoritamab

Rituximab

Lenalidomide

Oxaliplatin

Gemcitabine

BI 1819479A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

Recruiting

PHASE2

Sponsor:

Boehringer Ingelheim

Location:

Gulfport MS, Pensacola FL, Birmingham AL, Franklin TNshow 15 more

Code:

NCT06335303

Conditions

Idiopathic Pulmonary Fibrosis

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

BI 1819479

Placebo matching BI 1819479

OrforglipronA Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities

Recruiting

PHASE3

Sponsor:

Eli Lilly and Company

Location:

Gulfport MS, Lafayette LA, Atlanta GA, Houston TXshow 11 more

Code:

NCT06672939

Conditions

Obesity

Overweight

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

Orforglipron

Placebo

BI 1839100A Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis

Recruiting

PHASE2

Sponsor:

Boehringer Ingelheim

Location:

Gulfport MS, Birmingham AL, Kissimmee FL, Spartanburg SCshow 21 more

Code:

NCT06360094

Conditions

Idiopathic Pulmonary Fibrosis

Progressive Pulmonary Fibrosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BI 1839100

Placebo

MELT-300A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)

Recruiting

PHASE3

Sponsor:

Melt Pharmaceuticals

Location:

Bay Saint Louis MS, Jacksonville FL, Conway SC, Hagerstown MDshow 8 more

Code:

NCT06383273

Conditions

Cataract

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

MELT-300 sublingual tablet

Midalozam sublingual tablet

Placebo sublingual tablet

GEn-1124A Study of GEn-1124 in Subjects with Acute Respiratory Distress Syndrome (ARDS)

Recruiting

PHASE2

Sponsor:

GEn1E Lifesciences

Location:

Ocean Springs MS, Houston TX, Saint Louis MO, Kansas City KSshow 4 more

Code:

NCT05795465

Conditions

Respiratory Distress Syndrome, Acute

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

GEn-1124

Placebo